Details

Autor(en) / Beteiligte

• Donovan, Lucas M
• McDowell, Jennifer A
• Pannick, Anna P
• Pai, James
• Bais, Anthony F
• Plumley, Robert
• Wai, Travis Hee
• Grunwald, Gary K
• Josey, Kevin
• Sayre, George G
• Helfrich, Christian D
• Zeliadt, Steven B
• Hoerster, Katherine D
• Ma, Jun
• Au, David H

Titel

Protocol for a pragmatic trial testing a self-directed lifestyle program targeting weight loss among patients with obstructive sleep apnea (POWER Trial)

Ist Teil von

• Contemporary clinical trials, 2023-12, Vol.135, p.107378-107378, Article 107378

Ort / Verlag

United States

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• Obesity comprises the single greatest reversible risk factor for obstructive sleep apnea (OSA). Despite the potential of lifestyle-based weight loss services to improve OSA severity and symptoms, these programs have limited reach. POWER is a pragmatic trial of a remote self-directed weight loss care among patients with OSA. POWER randomizes 696 patients with obesity (BMI 30-45 kg/m2) and recent diagnosis or re-confirmation of OSA 1:1 to either a self-directed weight loss intervention or usual care. POWER tests whether such an intervention improves co-primary outcomes of weight and sleep-related quality of life at 12 months. Secondary outcomes include sleep symptoms, global ratings of change, and cardiovascular risk scores. Finally, consistent with a hybrid type 1 approach, the trial embeds an implementation process evaluation. We will use quantitative and qualitative methods including budget impact analyses and qualitative interviews to assess barriers to implementation. The results of POWER will inform population health approaches to the delivery of weight loss care. A remote self-directed program has the potential to be disseminated widely with limited health system resources and likely low-cost.